DelveInsight’s Metastatic Prostate Cancer Pipeline report depicts a robust space with 80+ active players working to develop ...

By creating artificial aging in mice, researchers at Lund University in Sweden have been able to track the formation of ...

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored ...

The combination of cabozantinib and atezolizumab appeared more effective than switching ARPI therapy in patients with mCRPC and extrapelvic soft-tissue metastases.

In 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths worldwide, according to the World ...

Increased mitogen-activated protein kinase signaling, mediated by oncogenes such as ERBB2 or HRAS, can cause ligand-independent activation of the androgen receptor. [10, 11] The kinases and ...

Several of these studies of signal transduction by the (pro)renin receptor used nanomolar concentrations of renin and prorenin that were several orders of magnitude higher than circulating levels. 5,7 ...

Interdisciplinary Genitourinary Cancer Forum featured a metastatic castration resistant prostate cancer (mCRCP) session and a ...

The Interdisciplinary Genitourinary Cancer Forum 2025, held between June 19 – 21, 2025 held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 7: Non-metastatic ...

Synthetic chemicals and plastics are useful and indispensable in our lives. On the other hand, the world is grappling with ...